Clinical Trial Detail

NCT ID NCT02938442
Title Vaccination of Triple Negative Breast Cancer Patients
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Arkansas
Indications

triple-receptor negative breast cancer

Therapies

Montanide ISA 51 + P10s-PADRE

Age Groups: senior adult

No variant requirements are available.